C-Biotech SRL
1.8 FTEC-Biotech reported revenue of 97,133 € for the 2024 financial year (annual accounts filed with the NBB on 27 Jun 2025), with 1.8 full-time equivalent.
The score of C-Biotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
C-Biotech's annual accounts
| 2024 | 2023 | |
|---|---|---|
| Revenue | 97,133 € | |
| Net result | −628,639 € | |
| Equity | 194,724 € | |
| Cash | 615,584 € | |
| EBITDA | −544,131 € | |
| Total assets | €2.67m |
Filed annual accounts
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
C-Biotech's financial analysis
- Solvency7.3%sector median: 41.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of C-Biotech
C-Biotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0794.909.852
- VAT number
- BE0794909852
- Peppol
- Registered · 0208:0794909852 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2022
- Registered office
- 9140 Temse
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2024 · filed on 27 Jun 2025
- Activity
- Remediation activities and other waste management service activities (NACE 39000)
C-Biotech (SRL) has been based in Temse since 2022, active in: remediation activities and other waste management service activities. For 2024, it reports revenue of 97,133 €, a net loss of 628,639 € and equity of 194,724 €. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.3%, below the median of its sector (41.0%).
Companies similar to C-Biotech
Companies in the same business, of comparable size and area, outside its group.
- Recycling Remediation activities and other waste management service activities Wetteren · balance sheet €2.67m
- Advanced Environmental Solutions Remediation activities and other waste management service activities Beveren-Kruibeke-Zwijndrecht · balance sheet €3.57m
- BVA Remediation activities and other waste management service activities Schoten · balance sheet €1.42m
- Credim Remediation activities and other waste management service activities Stabroek · balance sheet 726,056 €
- GH Construct Remediation activities and other waste management service activities Vilvoorde · balance sheet 35,011 €
- Asbest Demontage België Remediation activities and other waste management service activities Wijnegem · balance sheet 12,344 €
- E40 Remediation activities and other waste management service activities Asse · balance sheet 3,416 €
- Ghemko Milieu Remediation activities and other waste management service activities Sint-Niklaas · balance sheet €1.02m
Frequently asked questions about C-Biotech
What is the revenue of C-Biotech?
According to the 2024 annual accounts filed with the NBB, the revenue of C-Biotech amounts to 97,133 €.
What is the VAT number of C-Biotech?
In Belgium, the VAT number is the company number prefixed with BE: BE0794909852 for C-Biotech, if the company is VAT-registered. Its company number (CBE) is 0794.909.852.
Where is the registered office of C-Biotech?
According to the CBE register, the registered office of C-Biotech is in 9140 Temse.
What is the equity of C-Biotech?
At the close of the 2024 financial year, the equity of C-Biotech amounts to 194,724 €, a solvency of 7.3% of total assets.
How many people work at C-Biotech?
1.8 full-time equivalents on average according to the 2024 social balance sheet.
Who manages C-Biotech?
The register lists 4 active mandates at C-Biotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of C-Biotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →